Identification of a novel immune microenvironment signature predicting survival and therapeutic options for bladder cancer

por Yan, Yilin, Huang, Zhengnan, Cai, Jinming, Tang, Pengfei, Zhang, Fang, Tan, Mingyue, Shen, Bing
Publicado 2020

TEAD4 as a Prognostic Marker Promotes Cell Migration and Invasion of Urinary Bladder Cancer via EMT

por Huang, Zhengnan, Yan, Yilin, Tang, Pengfei, Cai, Jinming, Cao, Xiangqian, Wang, Zeyi, Zhang, Fang, Shen, Bing
Publicado 2021

Mechanisms of Xiaozheng decoction for anti-bladder cancer effects via affecting the GSK3β/β-catenin signaling pathways: a network pharmacology-directed experimental investigation

por Zhuang, Jingming, Mo, Jiahang, Huang, Zhengnan, Yan, Yilin, Wang, Zeyi, Cao, Xiangqian, Yang, Chenkai, Shen, Bing, Zhang, Fang
Publicado 2023

Identification of glycogene-type and validation of ST3GAL6 as a biomarker predicts clinical outcome and cancer cell invasion in urinary bladder cancer

por Dalangood, Sumiya, Zhu, Zhen, Ma, Zhihui, Li, Jiaxuan, Zeng, Qinghe, Yan, Yilin, Shen, Bing, Yan, Jun, Huang, Ruimin
Publicado 2020

A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer

por Yan, Yilin, Cai, Jinming, Huang, Zhengnan, Cao, Xiangqian, Tang, Pengfei, Wang, Zeyi, Zhang, Fang, Xia, Shujie, Shen, Bing
Publicado 2021

Pyroptosis-Related Patterns Predict Tumor Immune Landscape and Immunotherapy Response in Bladder Cancer

por Yan, Yilin, Cao, Xiangqian, Wang, Zeyi, Huang, Zhengnan, Cai, Jinming, Tang, Pengfei, Yang, Chenkai, Zhang, Fang, Xia, Shujie, Shen, Bing
Publicado 2022

Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer

por Huang, Zhengnan, Yan, Yilin, Wang, Tengjiao, Wang, Zeyi, Cai, Jinming, Cao, Xiangqian, Yang, Chenkai, Zhang, Fang, Wu, Gang, Shen, Bing
Publicado 2022

Targeted disruption of sp7 and myostatin with CRISPR-Cas9 results in severe bone defects and more muscular cells in common carp

por Zhong, Zhaomin, Niu, Pengfei, Wang, Mingyong, Huang, Guodong, Xu, Shuhao, Sun, Yi, Xu, Xiaona, Hou, Yi, Sun, Xiaowen, Yan, Yilin, Wang, Han
Publicado 2016

Combination chemotherapy with Zyflamend reduced the acquired resistance of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway

por Xue, Yanshi, Yang, Lin, Li, Junzun, Yan, Yilin, Jiang, Qinghui, Shen, Lan, Yang, Shuai, Shen, Bing, Huang, Ruimin, Yan, Jun, Guo, Hongqian
Publicado 2018

PDE4B Induces Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Is Transcriptionally Suppressed by CBX7

por Huang, Zhengnan, Liu, Jiakuan, Yang, Jiale, Yan, Yilin, Yang, Chenkai, He, Xiao, Huang, Ruimin, Tan, Mingyue, Wu, Denglong, Yan, Jun, Shen, Bing
Publicado 2021

Establishment of an optimized orthotopic bladder cancer model in mice

por Cai, Jinming, Xie, Zhiwen, Yan, Yilin, Huang, Zhengnan, Tang, Pengfei, Cao, Xiangqian, Wang, Zeyi, Yang, Chenkai, Tan, Mingyue, Zhang, Fang, Shen, Bing
Publicado 2022

A prognostic model based on necroptosis-related genes for prognosis and therapy in bladder cancer

por Wang, Zeyi, Huang, Zhengnan, Cao, Xiangqian, Zhang, Fang, Cai, Jinming, Tang, Pengfei, Yang, Chenkai, Li, Shengzhou, Yu, Dong, Yan, Yilin, Shen, Bing
Publicado 2023

A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer

por Cai, Jinming, Xie, Haoran, Yan, Yilin, Huang, Zhengnan, Tang, Pengfei, Cao, Xiangqian, Wang, Zeyi, Yang, Chenkai, Wen, Jiling, Tan, Mingyue, Zhang, Fang, Shen, Bing
Publicado 2023

CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10–ERK signaling

por Huang, Zhengnan, Yan, Yilin, Zhu, Zhen, Liu, Jiakuan, He, Xiao, Dalangood, Sumiya, Li, Meiqian, Tan, Mingyue, Cai, Jinming, Tang, Pengfei, Huang, Ruimin, Shen, Bing, Yan, Jun
Publicado 2021